Contraceptive prevalence, any modern method in Czechia
Czechia: Contraceptive prevalence, any modern method was 77.6% in 2008. ▲ Rising
Contraceptive prevalence, any modern method in Czechia, 1970–2008
Source: Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division. Measured in % of married women ages 15-49.
Analysis
Czechia recorded 77.6% for contraceptive prevalence, any modern method in 2008. That is the highest value across all 5 years on record.
Compared with earlier readings it is up 13.0% on the previous year and up 23.6% over ten years.
Over the whole period, contraceptive prevalence, any modern method in Czechia peaked at 77.6% in 2008 and was at its lowest, 24.3%, in 1970.
That places Czechia 4th out of 113 countries with data for 2008, putting it in the top 10%.
Contraceptive prevalence, any modern method in Czechia, year by year
| Year | % of married women ages 15-49 | Change |
|---|---|---|
| 1970 | 24.3% | — |
| 1993 | 44.9% | +84.8% |
| 1997 | 62.8% | +39.9% |
| 2005 | 68.7% | +9.4% |
| 2008 | 77.6% | +13.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1970s | 24.3% | 24.3% | 24.3% | 1 |
| 1990s | 53.8% | 44.9% | 62.8% | 2 |
| 2000s | 73.2% | 68.7% | 77.6% | 2 |
Countries ranked near Czechia
More health data for Czechia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.7726 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,169 deaths per 1,000 people (2090)
- Number of infants who die before age 1 34 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -5.76 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0222 units per person (2025)
- Population ages 00-04, male, annual growth rate -5.46 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is contraceptive prevalence, any modern method in Czechia?
- Contraceptive prevalence, any modern method in Czechia was 77.6% in 2008, according to Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.
- What is the highest contraceptive prevalence, any modern method recorded in Czechia?
- The highest recorded value was 77.6% in 2008.
- What is the lowest contraceptive prevalence, any modern method recorded in Czechia?
- The lowest recorded value was 24.3% in 1970.
- How does Czechia rank for contraceptive prevalence, any modern method?
- Czechia ranks 4th out of 113 countries with data for 2008.
- Is contraceptive prevalence, any modern method rising or falling in Czechia?
- Over the last ten years it is up 23.6%. The long-run trend across the full record is rising.
- Where does this Czechia data come from?
- The figures come from Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as part of Contraceptive prevalence, any modern method (% of married women ages 15-49). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Contraceptive prevalence, any modern method is the percentage of married women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.